Date | Time | Source | Announcement |
---|---|---|---|
24 May 2004 | 07:00 AM | Transaction in Own Shares | |
21 May 2004 | 07:00 AM | Transaction in Own Shares | |
20 May 2004 | 07:00 AM | Global Bond Offer | |
20 May 2004 | 07:00 AM | Transaction in Own Shares | |
19 May 2004 | 07:00 AM | Transaction in Own Shares | |
14 May 2004 | 07:00 AM | Capital Group | |
12 May 2004 | 07:00 AM | Advanta | |
07 May 2004 | 09:00 AM | AGM Resolutions | |
06 May 2004 | 07:00 AM | Seroquel | |
05 May 2004 | 10:42 AM | Regulatory Approval | |
30 Apr 2004 | 06:30 PM | Doc re. Pricing Supplement | |
30 Apr 2004 | 06:21 PM | Doc re. Pricing Supplement | |
30 Apr 2004 | 02:36 PM | Doc re. Pricing Supplement | |
30 Apr 2004 | 02:31 PM | Doc re. Pricing Supplement | |
29 Apr 2004 | 04:41 PM | Result of Meeting | |
29 Apr 2004 | 10:00 AM | 1st Quarter Results - Part 2 | |
29 Apr 2004 | 10:00 AM | 1st Quarter Results - part 1 | |
28 Apr 2004 | 09:00 AM | Notice of Results | |
29 Mar 2004 | 04:00 PM | Director Shareholding | |
22 Mar 2004 | 03:00 PM | Tender Offer | |
22 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
19 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
18 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
17 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
15 Mar 2004 | 04:00 PM | Notice of AGM | |
15 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
12 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
11 Mar 2004 | 10:00 AM | Directorate Change | |
09 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
08 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
04 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
02 Mar 2004 | 12:00 PM | Director Shareholding | |
01 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
26 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
25 Feb 2004 | 10:00 AM | Annual Report and Accounts | |
24 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
23 Feb 2004 | 07:00 AM | REPURCHASE OF SHARES | |
20 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
19 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
16 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
13 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
12 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
11 Feb 2004 | 09:52 AM | Holding(s) in Company | |
11 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
09 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
04 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
03 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
02 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
29 Jan 2004 | 11:00 AM | Final Results - Part 2 of 2 | |
29 Jan 2004 | 11:00 AM | Final Results - Part 1 of 2 |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.